Sign in

CIK 0001439222 · Large accelerated filer

AGIOS PHARMACEUTICALS, INC.

Sign in to watch
Ticker
AGIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
617-649-8600
Business address
88 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
AGIOS PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$371,112
in 2 filings, $371K under 10b5-1 plans

Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Gheuens Sarah −$371K Chief Medical Officer sold 15% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-02-10 Biller Jonathan Chief Financial Officer Grant or award · Restricted stock units +11,000 11,000
2021-02-10 Biller Jonathan Chief Financial Officer Grant or award · Stock option (right to buy) +44,000 44,000
2021-02-10 Alenson Carman Principal Accounting Officer Grant or award · Restricted stock units +5,922 5,922
2021-02-10 Alenson Carman Principal Accounting Officer Grant or award · Stock option (right to buy) +2,961 2,961
2021-02-04 MARAGANORE JOHN Director Gift −3,415 26,757
2021-01-06 Car Bruce Chief Scientific Officer Option exercise +3,437 8,284
2021-01-06 Car Bruce Chief Scientific Officer Shares withheld for taxes −1,191 $44.09 $53K 7,093
2021-01-06 Car Bruce Chief Scientific Officer Option exercise · Restricted stock units −3,437 6,874
2020-12-03 Biller Jonathan Chief Financial Officer Option exercise +5,753 11,747
2020-12-03 Biller Jonathan Chief Financial Officer Shares withheld for taxes −1,707 $45.87 $78K 10,040
2020-12-03 Biller Jonathan Chief Financial Officer Option exercise · Restricted stock units −5,753 11,506
2020-10-15 Alenson Carman Principal Accounting Officer Grant or award · Restricted stock units +5,000 5,000
2020-09-02 Alenson Carman Principal Accounting Officer Sale −250 $39.93 $10K 184
2020-05-29 Scadden David Director Option exercise +1,878 3,849
2020-05-29 Scadden David Director Option exercise · Restricted stock units −1,878 0
2020-05-29 Clancy Paul J Director Option exercise +1,878 3,278
2020-05-29 Clancy Paul J Director Option exercise · Restricted stock units −1,878 0
2020-05-29 Foster-Cheek Kaye I Director Option exercise +1,878 5,478
2020-05-29 Foster-Cheek Kaye I Director Option exercise · Restricted stock units −1,878 0
2020-05-29 CLARK IAN T Director Option exercise +1,878 3,278

Page 45 of 48 · 941 trades